ArticleBMC gastroenterology2025
Trends in pancreatic cancer mortality among US adults, 1999-2023.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Deaths Mentioning Both Pancreatic Cancer and Renal Failure in the United States, 1999-2024: Temporal Trends and Disparities.Epidemiologia (Basel, Switzerland) · 2026Article
- Trends and Disparities in Mortality Involving Pancreatic Cancer and Pulmonary Embolism in the United States, 1999-2024: A CDC WONDER Analysis.Diseases (Basel, Switzerland) · 2026Article
- Article
- Reducing Complications in Pancreaticoduodenectomy.Cancers · 2026Review
- Trends in liver failure-related mortality among middle-aged and older adults with digestive system malignant tumors in the United States, 1999-2023.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPancreatic cancer (PC) is characterized by an extremely poor prognosis and a high mortality rate, posing a significant burden on society.
methodsWe analyzed PC mortality data from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) database from 1999 to 2023. Annual death counts and age-adjusted mortality rates (AAMRs) were calculated and stratified by sex, age, race/ethnicity, state, census region, and 2013 urbanization level. Temporal trends were evaluated using Joinpoint regression to estimate annual percent changes (APCs) and average annual percent changes (AAPCs) with 95% confidence intervals. Analyses by urbanization level were limited to 1999-2020 due to data availability.
resultsIn 2023, there were 49,441 deaths from PC in the United States, representing a 70.03% increase compared to 1999. During the same period, the AAMR for PC rose from 16.41 (95%CI: 16.22-16.60) to 17.33 (95%CI: 17.17-17.48) per 100,000 population, showing a statistically significant upward trend. This increase was observed in both males and females, with a more pronounced increase among males, with an AAPC of 0.24 (95%CI: 0.19-0.30). Age subgroup analysis revealed that individuals aged 55 and older had higher mortality rates, which continued to rise, while mortality rates declined among those under 55. Although the AAMR for non-Hispanic(NH) Black individuals declined from 1999 to 2023, with an AAPC of -0.19 (95% CI: -0.26 to -0.12), it remained the highest among all racial and ethnic groups, with an AAMR of 20.68 (95% CI: 20.14-21.22). Geographically, the Midwest exhibited a higher AAMR (18.72, 95% CI: 18.36-19.07) and a more pronounced growth trend (AAPC = 0.52, 95% CI: 0.46-0.59). In addition, non-metropolitan areas have higher AAPC (0.62, 95CI: 0.53-0.72). And in 2020, AAMR value is higher than that of metropolitan area.
conclusionPC remains a significant and rising burden in the United States, with notable disparities by sex, age, race/ethnicity, and region. These findings highlight the importance of targeted prevention strategies, such as smoking cessation and metabolic risk control, and improving access to specialized care in non-metropolitan areas. Strengthening early detection efforts and optimizing resource allocation may help reduce these disparities and improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.